Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

about

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

Item

http://www.wikidata.org/entity/Q35994071

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@ast

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@en

type

Item

label

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@ast

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@en

prefLabel

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@ast

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@en

P1476

Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!

@en

P2093

Paul H Hayashi

http://www.w3.org/2001/XMLSchema#string

Sean Hurley

http://www.w3.org/2001/XMLSchema#string

Wendy Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

New challenge of hepatorenal syndrome: prevention and treatment.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.

P304

15-6, 21-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2004.12.1625

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15620124

http://www.w3.org/2001/XMLSchema#string